Biotech and Pharmaceuticals
AstraZeneca says its China operations president under investigation
The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. Nurphoto | Getty Images AstraZeneca‘s China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down as much as 5.3%. It was not immediately clear whether the executive Leon Wang […]
Read More
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. […]
Read More
Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer’s drug, Leqembi, and other new products gain traction. […]
Read More
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company’s Covid vaccine and antiviral pill Paxlovid helped boost sales. The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to $2.95, up […]
Read More
CDC says 75 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
A quarter pounder with cheese, fries, and a drink arranged at a McDonald’s restaurant in El Sobrante, California, US, on Wednesday, Oct. 23, 2024. David Paul Morris | Bloomberg | Getty Images A deadly E. coli outbreak linked to McDonald‘s Quarter Pounders has led to 75 cases in 13 states, the Centers for Disease Control […]
Read More
Novo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Semaglutide, the active ingredient in Ozempic, was associated with a 40% to 70% lower risk […]
Read More
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Yet another study […]
Read More
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic, arguing that the medications are […]
Read More
Scotiabank says its 3 biotech ‘top pick’ stocks have more than 100% upside potential
Scotiabank has highlighted three biotechnology companies as its “top picks,” each with the potential to more than double in stock price over the next 12 months. The bank’s optimism for these companies and the broader biotechnology sector is partly based on anticipated changes in the macroeconomic environment. Greg Harrison, equity analyst at Scotiabank, said “macro […]
Read More
Lilly sues online vendors, medical spa over copycat weight-loss drugs
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which […]
Read More